Sign in

CIK 0001896212 · <br>Emerging growth company

CDT Equity Inc.

Sign in to watch
Ticker
CDT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
873272543
Phone
(646) 491 9132
Business address
4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
Former names
CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.

Securities

  • CDT Common Stock Nasdaq
  • CDTTW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 2 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-12-01 McNealey Jennifer Isacoff Director Grant or award · Stock Option (Right to Buy) +65,000 $5.51 $358K 65,000
2023-12-01 Farley Chele Chiavacci Director Grant or award · Stock Option (Right to Buy) +65,000 $5.51 $358K 65,000
2023-12-01 Charles Faith L. Director Grant or award · Stock Option (Right to Buy) +65,000 $5.51 $358K 65,000
2023-12-01 Bligh James Director Grant or award · Stock Option (Right to Buy) +223,634 $5.51 $1.2M 223,634
2023-09-22 Farley Chele Chiavacci Director Grant or award +15,000 15,000
2023-09-22 Farley Chele Chiavacci Director Grant or award · Warrants +15,000 $11.50 $173K 15,000
2023-09-22 Heilbron Jack Kendrick Former CEO,director&10% owner Option exercise +4,060,250 4,060,250
2023-09-22 Heilbron Jack Kendrick Former CEO,director&10% owner Other disposition −45,000 4,015,250
2023-09-22 Heilbron Jack Kendrick Former CEO,director&10% owner Option exercise · Warrants +754,000 $11.50 $8.7M 754,000
2023-09-22 Heilbron Jack Kendrick Former CEO,director&10% owner Other disposition · Warrants −45,000 $11.50 $518K 709,000

Page 5 of 5 · 90 trades